A Phase 1 Dose Escalation/expansion Study of GSK5764227 (GSK’227), a B7-homolog 3 (B7-H3) Protein Targeted Antibody-Drug Conjugate (ADC), in Patients with Advanced Solid Tumors, Including Gastrointestinal (GI) Cancers. Wasif M. Saif,Philippe Alexandre Cassier,Giuseppe Curigliano, Gennaro Daniele,John Frederick Hilton,Shigehiro Koganemaru, Ruben Kowalyszyn,Patricia LoRusso,Victor Moreno,Maria Eugenia Olmedo Garcia, Herman Andres Perroud,Stefan N. Symeonides,Noboru Yamamoto, Amine Aziez, Rana Anjum,John LaMacchia, Harjeet Sembhi, Nirav Ratia,Antoine ItalianoJournal of Clinical Oncology（2025）引用 0|浏览0AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
